Phyllodes Tumor

Key points
- Phyllodes tumors range from benign to malignant and often clinically mimic a fibroadenoma.
- Patients will present with a single discrete, nontender lump and may provide a history of increase in size.
- Phyllodes tumors are usually unilateral, single, well-circumscribed, mobile and firm in consistency.
- Imaging features are generally very similar to those of a fibroadenoma.
Phyllodes tumors range from benign to malignant and often clinically mimic a fibroadenoma. They are, however, distinct neoplastic lesions derived from monoclonal stromal cells and because of their malignant potential are managed by surgical excision.
Symptoms
Patients will present with a single discrete, nontender lump and may provide a history of increase in size.
Signs
Phyllodes tumors are usually unilateral, single, well-circumscribed, mobile and firm in consistency.
Radiology
Imaging features are generally very similar to those of a fibroadenoma.
Mammography
Phyllodes tumors appear as well-defined oval or round soft-tissue densities.
They have a lobulated or smooth-outline. Unlike fibroadenomas, calcification is rarely seen. The masses are frequently large and may grow quickly on sequential examinations.
Ultrasound
Phyllodes tumors tend to be well-circumscribed, lobulated or smooth-outlined, hypoechoic mass lesions with a homogeneous internal echo pattern. Cyst-like spaces may be seen within the stroma. Heterogeneity of the internal echo pattern may indicate associated hemorrhage or necrosis.
Frequently, phyllodes tumors are highly vascular on color-flow doppler, although this is unreliable in distinguishing benign from malignant change.
Pathology
Macroscopic Appearance
Phyllodes are usually well-circumscribed, firm, lobulated masses. The cut surface is yellowish-white and often has a mucoid consistency with obvious clefts surrounding "leaf-like processes" from which the lesion takes its name.
They may be indistinguishable from fibroadenoma.
Microscopic Appearance
Like fibroadenomas, phyllodes tumors are composed of a stromal and an epithelial element. The epithelia component comprises ductal structures with invaginations into the lumina caused by the proliferating stroma.
These are the "leaf-like" structures. The epithelial component, like that in fibroadenoma, may show varying degrees of usual-type hyperplasia. The significant component in these lesions however is the stroma which is invariably cellular. The appearance of the stroma ranges from regular cellularity similar to that seen in a cellular fibroadenoma to marked hypercellularity including mitoses which may be frequent and may include abnormal forms.
The appearance of the stromal cells varies from plump, regular spindle cells to pleomorphic cells with features of sarcomatous change.
These lesions are divided into low-grade, intermediate-grade and high-grade categories based on the presence and degree of stromal overgrowth, the cytologic characteristics of the stromal cells, the number of mitoses per 10 high-power microscope fields and the nature of tumor margin (pushing or infiltrative). No single feature has proved reliable in predicting clinical outcome; however, this constellation of characteristics has been shown by several small studies to be of some use.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsStudies still looking for link between cell phones and brain tumors
The heaviest users of cell phones may be at higher than average risk of being diagnosed with a brain tumor, according to a recent French study. But for most people, it’s still not clear if there’s added risk, the…
23 May 2014
NewsMeasure of circulating tumor cells may be better predictor of prostate cancer survival than PSA test
New research by USC Norris Comprehensive Cancer Center scientists demonstrates that measuring circulating tumor cells (CTCs) - the cells that spread cancer through the body – may be a better predictor of patient…
22 March 2014
NewsNew UT Arlington study links BPA and breast cancer tumor growth
UT Arlington biochemists say their newly published study brings researchers a step closer to understanding how the commonly used synthetic compound bisphenol-A, or BPA, may promote breast cancer growth. Subhrangsu…






